Cold Sore Treatment for Fever Blisters - Abreva 10% Docosanol, 0.07 oz Tube x 2

Abreva, a cold sore treatment containing 10 percent docosanol, has been clinically proven to shorten the healing time of cold sores. When used at the first sign of a tingle, this cream can help reduce the duration of associated symptoms such as tingling, pain, burning, and itching (1). Formulated to penetrate deep into the skin, Abreva creates a barrier around healthy skin cells, preventing the spread of the herpes simplex virus type 1 (HSV-1) (2). As the number one dermatologist-recommended cold sore treatment, Abreva can heal cold sores in as few as 2.5 days (1).

The convenient tube packaging makes Abreva easy to apply and carry with you, ensuring you have access to this effective cold sore treatment whenever you need it. Hormonal changes, cold weather, sunlight, stress, and fatigue are all common triggers for cold sore outbreaks, but with Abreva, you can start treating the problem immediately and experience faster healing.

According to laboratory data, Abreva's 10 percent docosanol formula penetrates deep into the skin to target the root cause of cold sores (2). When used at the first sign of a cold sore, the median healing time is 4.1 days, with 25 percent of users experiencing complete healing in just 2.5 days (1). Among over-the-counter (OTC) cold sore treatments, Abreva is the number one brand for cold sore relief (3).

In addition to its effectiveness, Abreva is an HSA and FSA eligible product, making it a convenient and accessible option for those with flexible spending accounts. With two 0.07 oz tubes of Abreva 10 Percent Docosanol Cold Sore Treatment, you can take control of your cold sore outbreaks and experience faster healing times.

(1) When used at the first sign, median healing time is 4.1 days, 25 percent of users healed in 2.5 days (2) Based on laboratory data (3) Among OTC cold sore treatments, when used at the first sign

product information: